In Focus
Advances in digital imaging, nanotech drive microscopy market to $11.4b by 2031
Advances in digital imaging, nanotech drive microscopy market to $11.4b by 2031
APAC is expected to see the fastest growth.
Affordability wall drives institutional exit from Thai healthcare stocks
Patient shift to public hospitals capped Thailand’s private healthcare growth at 3%.
HSA clears cancer-detecting AI for routine hospital use
Intelligent Scopes Corp secures regulatory green light for its new bladder cancer software.
Healthcare asset tracking to hit $22.4b as hospitals go digital
Market to adopt AI, 5G, and blockchain for healthcare efficiency.
US tariffs trigger 123% Singapore pharma output surge
Combined US and China markets account for 38% of all Singapore pharma exports.
Human microbiome drugs market to be valued at $2.13b by 2031
By end users, the hospitals & clinics segment held the largest market share in 2024.
Radjak launches rapid cardiac, stroke unit for urban emergencies
It may roll out the model across its urban hospitals as demand grows.
Respiratory CGT development remains limited as funding drops
However, R&D efforts on automation and AI are advancing manufacturing.
It's the most wonderful time of the year!
See you in 2026!
Breast cancer drugs market to be valued at $57.1b by 2031
By end user, hospitals accounted for about 46% of the total market value.
What lies ahead for the cell and gene therapy market?
Major investors have committed over $3.5b across cumulative deals.
Hong Kong plans wider primary-care network in reform push
Health centres will offer screening, health checks, and chronic-disease management.
Asia-Pacific to lead global medical device growth in 2026
Globally, the market is expected to rise to 7.3% in 2026.
Chang Gung Hospital targets bigger Philippine patient base
It’s focusing on cancer care and advanced surgery.
HMI Medical targets more overseas patients with robotic surgery push
It’s aiming at middle- to upper-income patients who want advanced procedures.
mRNA vaccine venture financing plunges 82% to $90m in 2025 YTD
The decline follows a $500m cut in grant support by the US HHS.
A1 Health phases out desflurane anaesthesia in Indonesia
It has lowered carbon emissions in operating rooms by 25%.